
An International Publisher for Academic and Scientific Journals
Author Login
Scholars Journal of Applied Medical Sciences | Volume-5 | Issue-02
Detection of Nosocomial Isolates Expressing an Extended Spectrum β-lactamase Phenotype in Port Sudan Teaching Hospitals, Red Sea State, Sudan
Abd Elrahman M. A.Osman, Shingray O H, Mohammed A.M, Al-fadhil A.Omer
Published: Feb. 27, 2017 |
196
152
DOI: 10.36347/sjams.2017.v05i02.036
Pages: 487-494
Downloads
Abstract
This study aimed to determine the frequency of extended spectrum beta lactamase producing strains among
gram negative bacilli causing nosocomial infections. In addition to determine the drug resistance pattern of using
pathogens isolated from nosocomial patients using Kirby-Bauer disc diffusion method. The present study was a
descriptive cross-sectional study conducted between September 2011 to September 2012 from hospitalized patients
suspected of having Gram negative diseases at Port Sudan teaching hospital in red sea state. Isolation and identification
of pathogenic bacteria were carried out following standard laboratory procedures. All isolates were tested to 14 types of
common antimicrobial uses. Identification of extended spectrum beta lactamase (ESBL) production was performed by
the double disk synergy test and double disk diffusion test. Collected data were analyzed by using Statistical Package for
Social Sciences (SPSS; Version 20). P value <0.05 were considered statistically significant. Accordingly, our results
showed 198 types of Gram negative bacteria isolated. The major isolates was E.coli (89/44.9%) and the least Gram
negative organism isolated were Klebsiella oxytoca, Serratia marcescens, Morganella morganii, Salmonella para typhi A
and Citrobacter koseri (1/0.5%). This difference was statistically significant (p 0.00). ESBL producing bacteria was
44.4%, and was mostly E.coli 63.6%. The maximum sensitivity was seen for amikacin (96.6%) the different was
statistically significant (p 0.00). While the maximum resistance was seen against Ceftriaxone, Ciprofloxacin and
Tetracycline (100%).